New data suggest that the burden of atherosclerosis on imaging might not be as indicative of major cardiovascular events as a person’s age and sex. 

The task force cited insufficient evidence as the driver behind the decision to forego recommending supplemental screening. 

These findings warrant serious consideration by physicians caring for pregnant women in the future, as the link between poor mental health and placental development remains “underappreciated.”

Researchers suggested these findings could be used as a noninvasive tool in creating more personalized treatment options for patients facing a cancer diagnosis that is invasive in nature. 

Breast density is known to drop over time, but the rate at which density decreases merits special attention, as it could be associated with a woman’s chance of developing cancer.

A team of experts recently developed the new system to differentiate between malignant and benign "second look" lesions on MRI for women with known breast cancer.

Since being approved by the U.S. Food and Drug Administration in 2011, DBT has become the most common method for breast cancer screening, and as of September 2022, 84% of all U.S. mammography screening facilities housed DBT units. 

When tested, the model achieved a performance comparable to that of human experts.